In Brazil, a volunteer, reported in the clinical trials of the vaccine against koronawirusowi, the upcoming company AstraZeneca and the University of Oxford died the authorities. Studies are safe and will continue, said the British University.
The Brazilian health authority has more Detailsciting the medical mystery.
“After a careful investigation of this case in Brazil we have no fear for the safety of clinical research; such as the Brazilian auditor, as an independent Commission recommended that the trial continue“transfer in a statement, the University of Oxford.
The newspaper “O Globo” reported, citing anonymous sources, that of the deceased participants of the study, a dose of vaccine and Placebo. The Agency, Bloomberg reports.
The third Phase of clinical trials on a vaccine, using the drop-down Anglo-Swedish group and also of the British school, with the participation of thousands of volunteers, in September suspended if discovered a serious disease if one of the participants. Since that time, studies were in the UK, South Africa, Brazil and India.
The Federal government of Brazil is planning the purchase of the vaccine from AstraZeneca and production in the centre of the biomedical research in Rio de Janeiro. Our company’s vaccine is one of the most promising projects from a variety of drop-down in the world drugs against Covid-19.
Brazil is one of the hardest hit by the pandemic koronawirusa countries in the world. Virus SARS-CoV-2 zakaziło there are more than 5.2 million people, of which more than 154 thousand died.